Pfizer
Utility Patent Applications

Last updated:

List of all Pfizer patents 264 in total

Status Patent
Application
Utility: Bicyclic-Fused Heteroaryl or Aryl Compounds External link
Filling date: 13 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: Methods of Controlling Morphology of Polymeric Nanoparticles External link
Filling date: 13 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES External link
Filling date: 13 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: Cyclic Peptides As C5a Receptor Antagonists External link
Filling date: 13 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: IL-15 Variants and Uses Thereof External link
Filling date: 13 Sep 2025 Issue date: 29 Aug 2019
Application
Utility: Tricyclic Compounds And Their Use As Phosphodiesterase Inhibitors External link
Filling date: 13 Sep 2025 Issue date: 29 Aug 2019
Application
Utility: Tetrahydroquinazoline Derivatives Useful as Anticancer Agents External link
Filling date: 13 Sep 2025 Issue date: 15 Aug 2019
Application
Utility: CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN External link
Filling date: 13 Sep 2025 Issue date: 8 Aug 2019
Application
Utility: ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH External link
Filling date: 13 Sep 2025 Issue date: 8 Aug 2019
Application
Utility: ANTIBODIES SPECIFIC FOR CD70 AND THEIR USES External link
Filling date: 13 Sep 2025 Issue date: 1 Aug 2019
Application
Utility: CHIMERIC ANTIGEN RECEPTORS TARGETING CD70 External link
Filling date: 13 Sep 2025 Issue date: 1 Aug 2019
Application
Utility: Substituted Quinazoline and Pyridopyrimidine Derivatives Useful as Anticancer Agents External link
Filling date: 13 Sep 2025 Issue date: 1 Aug 2019
Application
Utility: NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF External link
Filling date: 13 Sep 2025 Issue date: 1 Aug 2019
Application
Utility: COMPOSITIONS AND METHODS FOR TREATING INTRACEREBRAL HEMORRHAGE External link
Filling date: 13 Sep 2025 Issue date: 1 Aug 2019

Showing 250 to 264 of 264 patents.